The Global Continuous Renal Replacement Therapy (CRRT) Market is Projected to Reach US$1.6 Billion by 2025, Growing at a CAGR of 6.1%
The global Continuous Renal Replacement Therapy (CRRT) market is projected to reach US$1.5 billion by 2025, driven by the growing incidence of acute kidney injury (AKI) and the resulting rise in hemodynamically unstable patients.
Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Continuous Renal Replacement Therapy (CRRT) market. The segments covered in the study include Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration, Slow Continuous Filtration); Product (Dialysates & Replacement Fluids, and Disposables & Systems) ). Market estimates and projections/forecasts are provided for World, United States, Canada, Japan, China, Europe (France, Germany, Italy, United Kingdom, and Rest of Europe), Asia-Pacific, Rest of World.
7 June 5:56 A.M., California/Marketwire/ - According to the new market research report, the global Continuous Renal Replacement Therapy (CRRT) market is projected to reach US$1.5 billion by 2025, driven by the growing incidence of acute kidney injury (AKI) and the resulting rise in hemodynamically unstable patients. Few of the factors leading to AKI include sudden blockage of urine due to enlarged prostrate or kidney stones; kidney toxicity caused by medications; autoimmune kidney diseases such as acute nephritic syndrome and interstitial nephritis; and accidental trauma or injury to the kidneys. The aging population and the increase in the number of hospitalized elderly are also pushing up the incidence of AKI. This is because older patients in ICU with high blood pressure, chronic liver or heart diseases are at a high risk of having AKI.
Major trends influencing growth in the market include higher than market average growth of Continuous Venovenous Hemodialysis (CVVHD); rising incidence of diabetes which is a key risk factor for acute kidney failure; increasing incidence of cardiovascular disease; growing interest in the development of CRRT systems for pediatric patients; continuous technology innovation such as development of new hemofilters with semipermeable membrane designed with hollow fiber that allows blood to flow into the hollow fibers while simultaneously enabling dialysate to flow outside; and growing prominence and commercial value of multifunctional machines capable of other extracorporeal blood treatments such as therapeutic plasma exchange and Hemoperfusion.
The United States and Europe represent large markets worldwide with a combined share of 62.8%. China ranks as the fastest growing market with a 9.1% CAGR over the analysis period supported by emerging new data which suggests kidney disease in the country to spiral over the next 10 to 20 years given the increase in risk factors of chronic kidney diseases in Chinese adults. As the country's healthcare system braces for a significant increase in disease burden given the growth of diabetic kidney disease patients, national kidney disease surveillance system is being established for early diagnosis and treatment. The emerging kidney care scenario bodes well for the adoption of CRRT in the healthcare system. Asia-Pacific excluding China follows next with a 8.7% CAGR led by developing healthcare infrastructure and emerging medical tourism opportunities in India, Singapore and other Southeast Asian countries.Competitors identified in this market include, among others, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bellco Societa Unipersonale a r.l, Chongqing Shanwaishan Science and Technology Co., Ltd., Fresenius Medical Care AG & Co. KgaA, Infomed SA, Medica SpA, Medical Components, Inc., Medites Pharma Spol. S.R.O., Medtronic PLC, Nikkiso Co., Ltd., Ningbo Tianyi Medical.
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. All analysis and findings published in the report are based on validated engagements from a total executive pool size of 5928. Among this pool, 948 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 178 unique participations, a total of 81 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world's only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.
Director, Corporate Communications
Global Industry Analysts, Inc.